Study of Butorphanol, Dezocine and Dexmedetomidine in the Field of Accelerated Recovery of Gynecological Malignancies

Abstract

Reducing the adverse stress response of patients in the perioperative period is the most basic principle of accelerated rehabilitation. It is well known that surgery will prompt the body to produce a corresponding stress response, thereby stimulating the body to release various hormones and inflammatory mediators, resulting in enhanced catabolism, which is not conducive to the healing of incisions and wounds. However, a series of measures of accelerated recovery in the perioperative period are precisely to reduce the occurrence of adverse stress reactions in patients. The purpose of this study is to systematically evaluate the efficacy and safety of the concept of fast recovery surgery in the operation of gynecological malignant tumors with the help of Meta analysis method, and to evaluate the efficacy and safety of fast recovery surgery concept in gynecological malignant tumor surgery. The use in tumor patients provides a basis for clinical surgeons to explore the best perioperative treatment plan. The experimental results show that the heart rate wake-up period of patients who use butorphanol 2 mg and dexmedetomidine 0.5 μg is shorter. For dezocine 10 mg and dexmedetomidine 0.5 μg, the heart rate wake-up time of group A was 68.82 minutes and 71.23 minutes, respectively. Butorphanol 2 mg and dexmedetomidine 0.5 μg were used to accelerate the recovery of patients with gynecological malignant tumors. have a certain effect.